Pharmbiosol SRL
Pharmbiosol reported total assets of 47,259 € at the end of the 2025 financial year (annual accounts filed with the NBB on 20 Jul 2026).
The score of Pharmbiosol shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -37 % Total assets +22 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmbiosol's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −16,970 € | ||||
| Equity | 20,840 € | ||||
| Cash | 18,532 € | ||||
| EBITDA | −3,638 € | ||||
| Total assets | 47,259 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Jul 2026
- Year ended 31 Dec 2024filed on 02 Jun 2025
- Year ended 31 Dec 2023filed on 25 Jun 2024
- Year ended 31 Dec 2022filed on 08 Jun 2023
- Year ended 31 Dec 2021filed on 27 Jun 2022
Pharmbiosol's financial analysis
- Solvency44.1%sector median: 50.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmbiosol
Pharmbiosol's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0599.848.790
- VAT number
- BE0599848790
- Peppol
- Registered · 0208:0599848790 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Mar 2015
- Registered office
- 4000 Liège
- Latest accounts
- 2025 · filed on 20 Jul 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Pharmbiosol (SRL) has been based in Liège since 2015, active in: business and other management consultancy activities. For 2025, it reports a net loss of 16,970 € and equity of 20,840 €; its revenue is not published. Its solvency stands at 44.1%, below the median of its sector (50.1%).
Companies similar to Pharmbiosol
Companies in the same business, of comparable size and area, outside its group.
- MVS-Invest Business and other management consultancy activities Kapellen · balance sheet 671,917 €
- SD Project & Management Business and other management consultancy activities Walhain · balance sheet 386 €
- LCH Consulting Business and other management consultancy activities Walcourt · balance sheet 109,286 €
- TG Consulting Business and other management consultancy activities Genappe · balance sheet 48,750 €
- Management Financial Engineering Consulting Business and other management consultancy activities Chastre · balance sheet 44,771 €
- Build Your Energy Business and other management consultancy activities Court-Saint-Étienne · balance sheet 44,621 €
- Stern Business and other management consultancy activities Ingelmunster · balance sheet 50,462 €
- AlphaTech Solutions Business and other management consultancy activities Genappe · balance sheet 44,203 €
Frequently asked questions about Pharmbiosol
What is the revenue of Pharmbiosol?
Pharmbiosol files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmbiosol?
In Belgium, the VAT number is the company number prefixed with BE: BE0599848790 for Pharmbiosol, if the company is VAT-registered. Its company number (CBE) is 0599.848.790.
Where is the registered office of Pharmbiosol?
According to the CBE register, the registered office of Pharmbiosol is in 4000 Liège.
What is the equity of Pharmbiosol?
At the close of the 2025 financial year, the equity of Pharmbiosol amounts to 20,840 €, a solvency of 44.1% of total assets.
Who manages Pharmbiosol?
The register lists 2 active mandates at Pharmbiosol. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmbiosol
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →